Skip to main content
GRX logo

GRX · Gabelli Healthcare & WellnessRx Trust

Track GRX — free
$10.14 +0.11 (+1.10%) At close · Aug 21
Market Cap
$149.30M
Shares
15.05M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.14 Open$10.04 Day$10.02–10.18 52W close$8.87–10.15 Avg vol 30d22K Short int6K · 0.0% float · 1.0d Short vol32% DataJan 2020–Aug 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.1 · calm Equity put/call 0.51
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +7%
above
Price vs 50-day avg +6%
above
RSI (14) 70
neutral
MACD trend Positive
52-week position 99%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +6%
trailing
6-month return +2%
trailing
YTD return +5%
this year
Relative strength −10%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $10 › 200d $9 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +8 funds added
Insider flow Accumulating
Net +$258.0K over 90 days · 0% sells
Short interest Falling
0.04% of float · ▼ -57.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
50 holders — near 3-yr low, contrarian setup
Squeeze score 37
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 13%
annualized · 1-yr
Max drawdown −11%
past year
ATR 1.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 3 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+7% Bullish
Price vs 50-day avg
+6% Bullish
RSI (14)
70 Neutral
MACD trend
Positive Bullish
52-week position
99% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $10 › 200d $9 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +8 funds added
Insider flow Accumulating
Net +$258.0K over 90 days · 0% sells
Short interest Falling
0.04% of float · ▼ -57.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
50 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $9 Now $10 · 99% Range high $10
vs 200-day avg +7% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GRX
Gabelli Healthcare & WellnessRx Trust
this stock
$149.30M +5.3% 0.0%
BLK
BlackRock, Inc.
$370.39B +8.1% +16.2% 27.3 0.7%
BX
Blackstone Inc.
$106.10B -7.0% +9.2% 31.7 3.5%
KKR
KKR & Co. Inc.
$97.09B -14.9% -11.0% 1.6%
BN
BROOKFIELD Corp /ON/
$92.35B -9.2% 0.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
50
% held
39.1%
Net QoQ
-63.1K sh
Top holder
Saba Capital Management,…
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Falling
Shares short
5.6K
Days to cover
1.0d
Change
-7.5K sh
View
Short Volume
Short vol %
32%
As of
Aug 21, 2026
Short Total
View
Fails to Deliver
FTD shares
366
Value
$3.5K
As of
Jul 2, 2026
View
Off-Exchange
Off-exchange %
63.1%
Week of
Jul 13, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$258.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
8-K
Filed
May 7, 2026
This year
2
View
Exempt Offerings
Offering
$36.7M
Filed
Jan 24, 2024
View
Earnings & Events
Earnings Calls Upcoming
Next call
Apr 30, 2027
View
Investor Relations
Upcoming events
7
View

Performance

5D 20D 120D MTD YTD
GRX +2.2% +6.1% +1.8% +4.1% +5.3%
SPY -1.4% +3.6% +11.6% +2.5% +12.3%
vs SPY +3.6% +2.4% -9.8% +1.6% -7.0%

Capital returns

Latest dividend
$0.17 / share · ex Jun 15, 2026
Declared · upcoming
$0.17 / share · ex Sep 16, 2026
Raised 13.3%
Paid (TTM)
$0.68 / share · 4 payouts
Dividend yield (TTM, derived)
6.71%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1391437 CUSIP 36246K103 13F (30d) 45 filings 45 filers Visit website